Zenlabs Ethica Limited
BSE: ZENLABS.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Sanjeev Kumar Singal
- Employees
- 65
- Headquarters
- Chandigarh, India
- IPO year
- 2000
- Market cap
- ₹158.8M
- Website
- http://www.zenlabsethica.com
Loading ZENLABS…
Loading profile data…Frequently asked questions about ZENLABS
What does Zenlabs Ethica Limited (ZENLABS.BO) do?
Zenlabs Ethica Ltd. engages in trading of pharmaceutical products. Its products include: Analgesics and Anti-Inflammatory; Skin Preparations; Neurological Disorders; Ear, Eye, and Nasal Drops; Anti-Diabetic; Anti-Depressant; Antiviral; Anti-Emetic; Steroids and Anabolic Steroids; Anti-Hypertensive Drugs; Anti Allergic, Anti Cold, and Cough Syrup...
Where does ZENLABS.BO trade?
Zenlabs Ethica Limited (ZENLABS.BO) trades on the Bombay Stock Exchange.
What sector is ZENLABS.BO in?
Zenlabs Ethica Limited (ZENLABS.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Zenlabs Ethica Limited?
Sanjeev Kumar Singal is the chief executive officer of Zenlabs Ethica Limited (ZENLABS.BO).
Where is Zenlabs Ethica Limited headquartered?
Zenlabs Ethica Limited is headquartered in India.
Does ZENLABS.BO pay a dividend?
Zenlabs Ethica Limited (ZENLABS.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ZENLABS.BO go public?
Zenlabs Ethica Limited (ZENLABS.BO) completed its initial public offering in 2000.